Riskpilot← Back to searchSign inGet full accessIn Question AB
ABActiveOrg 5567236053Kungsgatan 91 D Lgh 1103Literary creation and musical composition activities · NACE 9011Est. 20070 employees
Revenue 2025
SEK 152K
+1589% vs 2024
EBITDA margin
80.3%
+655% vs 2024
Equity ratio
87.8%
Financial strength
Net profit 2025
SEK 110K
+788% vs 2024
| Revenue | SEK 152K | +1589% |
| EBITDA | SEK 122K | +655% |
| Net profit | SEK 110K | +788% |
| Total assets | SEK 378K | +48% |
| Equity | SEK 332K | +50% |
| Employees | 0 | — |
Legal name
In Question AB
Org number
5567236053
Legal form
Aktiebolag
NACE code
9011 · Literary creation and musical composition activities
Founded
14 februari 2007
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva föreläsningsuppdrag inom läkemedelsområdet, författande och försäljning av bokmanus inom främst läkemedels- området både nationellt och internationellt och därtill när- liggande konsultativ verksamhet och därmed förenlig verksamhet.
Address
Kungsgatan 91 D Lgh 1103
Phone
+46706839708
Email
claes.m.lundgren@outlook.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 51 | 77 | 12 | 9 | 152 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −28 | 40 | −27 | −22 | 122 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −28 | 40 | −27 | −22 | 122 |
| Net financials | — | — | — | 5 | 5 |
| Profit before tax | −28 | 40 | −27 | −16 | 127 |
| Tax | −0 | −0 | −0 | −0 | −17 |
| Net profit | −28 | 40 | −27 | −16 | 110 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 280 | 298 | 272 | 255 | 378 |
| Equity | 226 | 266 | 238 | 222 | 332 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 54 | 32 | 34 | 33 | 46 |
| Total debt | 54 | 32 | 34 | 33 | 46 |
EBITDA margin
80.3%
This company
15.8%
Market median
+408% vs market
20212025
Equity ratio
87.8%
This company
38.2%
Market median
+130% vs market
20212025
Return on equity
33.1%
This company
18.4%
Market median
+80% vs market
20212025
Net profit margin
72.4%
This company
8.1%
Market median
+794% vs market
20212025
Asset turnover
0.40×
This company
1.12×
Market median
-64% vs market
20212025
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
JO | Audit | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of In Question AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Ove Stefan Bengtsson | Audit | 0 companies |
| Claes Magnus Lundgren | Board of Directors | 0 companies |
| Anna Ingeborg Forssell | Deputy Board Member | 0 companies |